OTC Markets OTCPK - Delayed Quote USD

Talis Biomedical Corporation (TLIS)

1.4100
0.0000
(0.00%)
At close: June 12 at 8:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Rebecca Markovich Interim Chief Financial Officer 379.23k -- 1974
Ms. Margaret Barrett M.S. Controller -- -- --
Gillian Green Company Secretary -- -- --

Talis Biomedical Corporation

1375 West Fulton Market
Suite 700
Chicago, IL 60607
United States
(650) 433-3000 https://talisbio.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
99

Description

Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.

Corporate Governance

Talis Biomedical Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 26, 2025 at 12:30 PM UTC - March 31, 2025 at 12:30 PM UTC

Talis Biomedical Corporation Earnings Date

Recent Events

September 30, 2024 at 12:00 AM UTC

15-12G: Notice of termination of registration of a class of securities under Section 12(g)

September 17, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 9, 2024 at 12:00 AM UTC

S-8 POS: Offering Registrations

September 6, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 5, 2024 at 12:00 AM UTC

8-K/A: Corporate Changes & Voting Matters

September 3, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 23, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 19, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 14, 2024 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

August 6, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers